Author

Bing Feng

École Polytechnique Fédérale de LausannePrimary ORCID profile (0000-0002-6669-6640 · 7 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Bing FengiD7 papers · University of Utah

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Armand Kurum· 1 shared Chao Huang· 1 shared Cheng SuniD· 1 shared Guoxin CaiiD· 1 shared Li TangiD· 1 shared Massimo AndreattaiD· 1 shared Min Gao· 1 shared Santiago J. CarmonaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Armand Kurum

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC-I deficient solid tumors

Yi Wang, Chao Huang, Guoxin Cai, Massimo Andreatta, Armand Kurum, Yang Zhao, Bing Feng, Min Gao, Santiago J. Carmona, Zhan Zhou, Cheng Sun, Yugang Guo, Li Tang

This paper shows that IL-21-Fc reprograms NK cell metabolism to enhance their function against MHC-I deficient tumors, leading to tumor eradication in preclinical models.

Cell Reports · Feb 26, 2026Peer-reviewedCancer Biology